RSS

Molecular Profiles

Molecular Profiles and Maryland-based Xceleron recently announced a collaboration to assist drug developers with improved efficiency during clinical development. In an exclusive interview with EPM, we found out what this means for pharma. more

News

A new partnership means that contract research and manufacturing organisation Molecular Profiles will have access to Accelerator Mass Spectrometry (AMS) analytical technology – allowing it to compete on a larger scale. more

News

The company can now offer liquid filling into capsules, complementing its existing powder and semi-solid capsule filling capability. more

The collaboration that will support pharmaceutical and biotech drug developers during the pre-clinical and formulation development stage. more

Molecular Profiles, a subsidiary of Columbia Laboratories, Inc., is set to increase awareness and uptake of its pharmaceutical development services in the north American market following the appointment of head of US sales Charles Maher. more

Technology

Molecular Profiles, a subsidiary of Columbia Laboratories, Inc., has invested in GMP hot melt extrusion (HME) technology along with further milling equipment, enabling the company to accelerate formulation development for its clients. more

Technology

Pharmaceutical development and manufacturing services provider Molecular Profiles is set to host a seminar in the UK focused on overcoming biological barriers in drug development. The UK-based company, a subsidiary of Columbia Laboratories, will... more

Technology

CI Precision has been endorsed by Molecular Profiles, which recently integrated CI Precision’s SADE SP140 tablet and capsule weight sorter into its current systems. The Nottingham-based pharmaceutical development services specialist, dedicated to... more

Technology

Pharmaceutical formulation development and manufacturing services provider Molecular Profiles, a subsidiary of Columbia Laboratories, Inc., has been chosen by clinical stage biopharmaceutical company Telormedix SA to develop both topical and solid... more

Technology

Columbia Laboratories has acquired Molecular Profiles, a privately-held, cash-flow positive, UK-based pharmaceutical development services company, for cash and Columbia’s Common stock totalling approximately $25.0 million in aggregate. more

Technology

UK-based contract research and manufacturing organisation Molecular Profiles has opened the doors of its new facility following a successful inspection from the Medicines and Healthcare products Regulatory Agency (MHRA). more

Technology